ENDPQ — Endo International Share News
0.000.00%
Last trade - 00:00- $0.14m
- $7.37bn
- $2.01bn
Brief: Endo Enters Into Restructuring Support Agreement With Senior Secured Debtholders
Drugmaker Endo files for bankruptcy, lenders to take control (updated)
Massachusetts AG reaches settlement with opioid maker Endo
Brief: Endo International Files For Chapter 11 Bankruptcy - Court Filing
Media: Endo creditors eye plan for drugmaker's sale through bankruptcy - Bloomberg News
Press Digest: Wall Street Journal - Aug 10
Endo International plunges as blood pressure injection sales tumble
Brief: New Drug Filing For Cenobamate Accepted For Review In Canada And Israel
Endo International PLC reports results for the quarter ended in June - Earnings Summary
Brief: Endo Reports Q2 Revenue Of $569 Mln, Down 20%
Brief: Paladin Labs Announces Health Canada's Filing Acceptance Of Cenobamate Tablets As An Adjunctive Therapy
Company Made The Interest Payment Of About $38 Million With Respect To 2028 Notes
Brief: Buxton Helmsley Issues Letter To Endo International PLC Directors, Relating To Financial Disclosures
Brief: Endo Announces Agreement For Paladin Labs To Develop And Supply Quoin Pharmaceuticals' Qrx003 In Canada
Brief: Endo International Will Not Make Interest Payments Of About $1.9 Mln Due On July 15 For Notes due 2023
Endo International shares tumble after report of bankruptcy filing
Brief: Endo International Received Notice Of Delisting From Nasdaq
Brief: Opana ER Antitrust Trial Concludes With Jury Verdict In Endo's Favor
U.S. STOCKS ON THE MOVE-Micron, VerifyMe, HCA Healthcare, chipmakers